CXCL12 and neoplasm: IR reduces vascular diameter, activating hypoxia-inducible factor 1α (HIF1α) and vascular endothelial growth factor (VEGF), provoking the release of chemokine (C-X-C motif) ligand 12 (CXCL12), which altogether protect tumour cells from cellular stress and death.